Harmony Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Business Updates

Go back to Harmony Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Business Updates

Harmony Biosciences (HRMY) Tops Q4 EPS by 28c

February 28, 2022 7:33 AM EST

Harmony Biosciences (NASDAQ: HRMY) reported Q4 EPS of $0.63, $0.28 better than the analyst estimate of $0.35. Revenue for the quarter came in at $91.2 million versus the consensus estimate of $91.33 million.

For earnings history and earnings-related data on Harmony Biosciences (HRMY) click here.

... More